Clinical Trials at Dana Farber Cancer Institute

As of September 2026, 210 paid clinical trials are recruiting at Dana Farber Cancer Institute, located at 44 BINNEY ST, BOSTON, MA 02115-6013, phone (617) 632-3497 in Boston, Massachusetts. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

View the full facility profile →

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

211 clinical trials at Dana Farber Cancer Institute

·Clear filters·

Get a weekly email when new trials open in Boston, MA.

High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study

for Pediatric Brain Tumor

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 45·Accepts healthy volunteers

Code: NCT05740839·Recruiting·Listed Feb 2023

Apply to this trial

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

for Melanoma

Drug: Ipilimumab

Sites in Boston +3 more locations

Sponsor: NYU Langone Health

Sex: All·Age: 18 - 100

Code: NCT05428007·Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

for Breast Cancer

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: Female·Age: 18 - 59·Accepts healthy volunteers

Code: NCT06322888·Recruiting·Listed Mar 2024

Apply to this trial

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

for Immune Checkpoint Inhibitor-Related Colitis

2 locations in Boston

Sponsor: Shilpa Grover, MD, MPH

Sex: All·Age: 18+

Code: NCT06841705·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

for Advanced Prostate Cancer

2 locations in Boston

Sponsor: Brigham and Women's Hospital

Sex: Male·Age: 18+

Code: NCT06062745·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Acute Myeloid Leukemia

1 location in Boston

Sponsor: Eric Stephen Winer, MD

Sex: All·Age: 18+

Code: NCT05703542·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

BRIDGE-SIC Efficacy Trial

for Cancer

2 locations in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT07735442·Recruiting·Listed Jul 2026

Apply to this trial

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

for Metastatic Bladder Cancer

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT07548476·Recruiting·Listed Apr 2026

Apply to this trial

Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia

for Leukemia, Myeloid

Drug: Venetoclax

2 locations in Boston

Sponsor: Jacqueline Garcia, MD

Sex: All·Age: 18 - 90

Code: NCT07439211·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

ALL Backbone in AYAs

for Acute Lymphoblastic Leukemia

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 51

Code: NCT07227584·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial